Ridiculous, how many times has this stock done this in the past few months. This is a day trader stocks wet dream. Basing a biotechs numbers on earnings is ridiculous, everyone here who talks fundamentals should please stop, this stock has never held according to any of the fundamental charts.
Makes me feel all warm and fuzzy on the inside.
Pointless thread and yes I know that I'm long and this won't matter in the end game but honestly, these drops are ridiculous.
With the biotech sector firing on all cylinders these past few days, I wonder if this down day helped some investors/mm look to new markets, such as Curis.
Especially with the $5 barrier being broken and 52 week high being tested, perhaps this big down day is a blessing in disguise for Curis.
Ya, I think we can say that the $4.50-$5.00 range is going to be this stocks price for the next 3 months.
Not sure how the price is not going up though. Bios sore based on the kind of kindling info that Curis has. Between a proven product, albeit small royalties, with the remainder of the pipeline and a lower than avg risk thanks to Erivedge, I just dont see why this price isnt in the mid $5s now.
Yikes, $270,000 in royalties is peanuts. I know those are partial quarter results but I still would have liked to see more than $270,000 in royalties. What does that work out to, about 4 million in Erivedge sales and 7% royalty rate?
I don't think we will see much movement on the stock today. More positive in the CC than negative but not enough for us to see a nice 5% jump for the day.
Good news indeed.
But should the approval and submission of Erivedge in other countries really be a surprise to anyone at this point.
Lets hope this timing is planned to build up momentum into the Q1 CC.
Lets see $5.00 by the end of this week and I'll be happy.
These afternoon slumps are becoming tiresome. Any thoughts in regard to this pattern. Curis has shown a high buy/sell ratio but small sell volume has killed any kind of momentum in the afternoon.
You know what's crazy though, what makes this stock all of a sudden jump as so like it did today. I mean, you figure it would be on a day with news or a day with some kind of landmark info. But no, it's on a Tuesday near the end of Q1.
Really makes you wonder how the stock market works.
Yes, I'm a complainer, everyone knows why over the past two months, we've all been frustrated. But these past 2 days have given me a completely different perspective to view this stock.
Instead of a gradual increase that we all wanted to see, this is going to be a blitzkrieg with the shorts. They thought the price could be kept down but obviously after the volume we've seen and the constant positive news, the realization is going to hit them that they need to get out of the way of this freight train. We should see chunks of shares being eaten up this week.
By week end, we should be pushing the 52-week high if all goes according to plan.
Lets hope this isn't another anomaly and we can hold these gains.
Definitely BigL, the other shoe has officially dropped today.
It appears the shorts are going to realize that they don't have the luxury of waiting out this stock to see what doctors think of Erivedge. They're going to need to start scrambling and if the market can at least hold stagnant. I see Curis going up quickly this week.
As an investor that is awesome news.
But on a more humane level, that is so great to hear these people finally have the possibility to have a normal life. I hope the side effects are minimal not just for Curis' stock price but for these people who are looking to Erivedge as their only hope.
It seems that sometimes in biotechs, people forget the direct impact that these drugs can have on someone.
Thanks for the article dd
It's outright frustrating how Curis can't hold a decent gain. We go up 4% only to be knocked right back down. And if we hold that gain for the day, then it's almost a guarantee that we will see those gains lost over the following 2 days.
I've never seen so much good news for a stock with absolutely no positive price impact.